What challenges do Canadian researchers face in bringing immunotherapies to patients in the health care system?
This Cancer Immunotherapy Month, we ask Canadian researchers to talk about the complex journey immunotherapies face as they go from labs to patients.
At the recent BioCanRx Preclinical Development Workshop, we asked two experts to provide insight into the necessary preclinical steps. Dr. Jeanette Boudreau, associate professor at Dalhousie University Scientific Director of the Beatrice Hunter Cancer Institute and Mathieu Gigoux, PhD, Head of Tests and Process Development (GMP/GLP) – TIL Cellular Production Unit at Centre de recherche du CHUM, share perspectives on the opportunities and challenges ahead in their own words.